Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Health Care Stocks Edge Higher Premarket Tuesday

10/12/2021 | 09:16am EST


ę MT Newswires 2021
All news about GLAXOSMITHKLINE PLC
11/24BiondVax Pharmaceuticals Schedules Shareholder Meeting Amid Preparations to Produce VHH..
MT
11/24GLAXOSMITHKLINE : UBS reiterates its Neutral rating
MD
11/23GLOBAL MARKETS LIVE : Samsung, Clariant, AstraZeneca, Amazon, Merck...
11/23Health Care Stocks Flat Ahead of Tuesday's Opening Bell
MT
11/23GLAXOSMITHKLINE : Gets a Buy rating from Berenberg
MD
11/22GlaxoSmithKline Secures Exclusive License Deal for Arrowhead's Liver Disease Treatment
MT
11/22Arrowhead Pharmaceuticals Reports Wider Fiscal 2021 Loss, Signs License Deal With GSK f..
MT
11/22Arrowhead Pharma in License Agreement With GSK for ARO-HSD
DJ
11/22GLAXOSMITHKLINE : UBS remains Neutral
MD
11/22Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy developm..
RE
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2021 33 843 M 45 145 M 45 145 M
Net income 2021 4 027 M 5 373 M 5 373 M
Net Debt 2021 20 703 M 27 617 M 27 617 M
P/E ratio 2021 18,7x
Yield 2021 5,30%
Capitalization 75 660 M 101 B 101 B
EV / Sales 2021 2,85x
EV / Sales 2022 2,69x
Nbr of Employees 94 066
Free-Float 92,3%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | MarketScreener
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 15,11 GBX
Average target price 1 675,24 GBX
Spread / Average Target 10 988%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC14.75%102 756
JOHNSON & JOHNSON1.82%421 847
ROCHE HOLDING AG17.17%334 769
PFIZER, INC.38.25%285 639
NOVO NORDISK A/S68.76%247 704
ELI LILLY AND COMPANY55.18%237 527